Recruiting Peripheral Artery Disease Studies in Minneapolis
SMART Exercise for PAD
Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lowe...
The COCOA-PAD II Trial
Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...
About Peripheral Artery Disease Clinical Trials in Minneapolis
Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.
There are currently 2 peripheral artery disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 400 participants. Research is being sponsored by Northwestern University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral Artery Disease Clinical Trials in Minneapolis — FAQ
Are there peripheral artery disease clinical trials in Minneapolis?
Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What peripheral artery disease treatments are being tested?
The 2 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.
Data updated March 2, 2026 from ClinicalTrials.gov